[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100582347":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":29,"centralContacts":33,"locations":39,"responsibleParty":85,"collaborators":88,"id":94,"slug":37,"hasResults":95,"nctId":96,"briefTitle":97,"officialTitle":98,"acronym":99,"eligibilityCriteria":100,"healthyVolunteers":95,"sex":101,"minAge":102,"maxAge":103,"enrollmentInfo":104,"targetDuration":37,"studyType":107,"phases":108,"briefSummary":110,"conditions":111,"keywords":114,"overallStatus":42,"whyStopped":37,"lastUpdateSubmitDate":118,"lastUpdatePostDateStruct":119,"startDateStruct":122,"completionDateStruct":124,"leadSponsor":126,"locationsCount":127},{"fullName":5,"class":6},"Linkoeping University","OTHER_GOV",[8,14],{"label":9,"type":10,"description":9,"interventionNames":11},"OGTT at the clinic then at home","EXPERIMENTAL",[12,13],"Diagnostic Test: OGTT at home using CGM","Diagnostic Test: OGTT at the clinic",{"label":15,"type":10,"description":15,"interventionNames":16},"OGTT at home then at the clinic",[12,13],[18,24],{"type":19,"name":20,"description":20,"armGroupLabels":21,"otherNames":22},"DIAGNOSTIC_TEST","OGTT at home using CGM",[15,9],[23],"OGTT-home",{"type":19,"name":25,"description":25,"armGroupLabels":26,"otherNames":27},"OGTT at the clinic",[15,9],[28],"OGTT-clinic",[30],{"name":31,"affiliation":5,"role":32},"Peder af Geijerstam, MD, PhD","PRINCIPAL_INVESTIGATOR",[34],{"name":31,"role":35,"phone":36,"phoneExt":37,"email":38},"CONTACT","+46739597426",null,"peder.af.geijerstam@liu.se",[40,58,70],{"facility":41,"status":42,"city":43,"state":44,"zip":45,"country":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"Primary Health Care Center Bra Liv Rosenhälsan","RECRUITING","Huskvarna","Jönköping County","55185","Sweden",{"type":48,"coordinates":49},"Point",[50,51],14.30214,57.78596,{"lat":51,"lon":50},[54],{"name":55,"role":35,"phone":56,"phoneExt":37,"email":57},"Maria Samefors, MD, PhD","+46102423550","maria.samefors@liu.se",{"facility":59,"status":42,"city":60,"state":60,"zip":61,"country":46,"cosmosGeoPoint":62,"geoPoint":66,"contacts":67},"Primary Health Care Center Cityhälsan Centrum","Norrköping","60239",{"type":48,"coordinates":63},[64,65],16.1826,58.59419,{"lat":65,"lon":64},[68],{"name":31,"role":35,"phone":69,"phoneExt":37,"email":38},"+46101059140",{"facility":71,"status":42,"city":72,"state":73,"zip":74,"country":46,"cosmosGeoPoint":75,"geoPoint":79,"contacts":80},"Primary Care Center Vårdcentralen Kärna","Linköping","Östergötland County","58662",{"type":48,"coordinates":76},[77,78],15.62157,58.41086,{"lat":78,"lon":77},[81],{"name":82,"role":35,"phone":83,"phoneExt":37,"email":84},"Karin Rådholm, MD, PhD","+4613281756","karin.radholm@liu.se",{"type":32,"investigatorFullName":86,"investigatorTitle":87,"investigatorAffiliation":5,"oldNameTitle":37,"oldOrganization":37},"Peder af Geijerstam","Principal Investigator",[89,91],{"name":90,"class":6},"Region Jönköping County",{"name":92,"class":93},"Region Östergötland","OTHER","100582347",false,"NCT06862128","OGTT at Home Using CGM vs at the Clinic","Oral Glucose Tolerance Test at Home With Continuous Glucose Monitoring vs Standard Clinic-based Testing","OGTT-CGM","Inclusion Criteria:\n\n* Prediabetes indicated by ≥2 of the following values, measured at separate occasions or through different analyses during the past 2 years:\n* \\- Fasting venous plasma glucose ≥6.1 but ≤6.9 mmol\u002FL\n* \\- Non-fasting venous plasma glucose ≥7.8 but ≤11.0 mmol\u002FL\n* \\- HbA1c ≥39 but ≤47 mmol\u002Fmol\n* Access to a smart phone which is compatible with the CGM application and has working Bluetooth connectivity\n* Ability to read and respond to online instructions and questionnaires in Swedish.\n\nExclusion Criteria:\n\n* T2D indicated by ≥2 of the following values, measured at different occasions or through different analyses:\n* \\- Fasting venous plasma glucose ≥7.0 mmol\u002FL\n* \\- Non-fasting venous plasma glucose value ≥11.1 mmol\u002FL\n* \\- HbA1c ≥48 mmol\u002Fmol\n* Previous bariatric surgery e.g., gastric by-pass or gastric sleeve surgery\n* Body mass index \\\u003C20 kg\u002Fm2\n* Body weight \\\u003C43 kg\n* Current pregnancy\n* Need of regular use of GLP-1 receptor agonists, SGLT-2 inhibitors, acetaminophen or ascorbic acid supplements during the study period\n* Fear of needle sticks\n* Shift work during the study period\n* Involvement in the study design, data collection, analysis, or participant recruitment.","ALL","18 Years","70 Years",{"count":105,"type":106},75,"ESTIMATED","INTERVENTIONAL",[109],"NA","This randomized, crossover study evaluates the feasibility and accuracy of a self-administered oral glucose tolerance test (OGTT) at home using continuous glucose monitoring (CGM) compared to a standard clinic-based OGTT. Participants with prediabetes will undergo both home-based and clinic-based OGTTs, with glucose levels measured via CGM and venous plasma glucose. The primary outcome is the correlation between CGM-based glucose values and standard OGTT results. Secondary outcomes include diagnostic agreement, metabolic hormone associations, and feasibility of home-based testing as a diagnostic tool for dysglycemia.",[112,113],"Pre-diabetes","Diabetes",[112,113,115,116,117],"Oral glucose tolerance test","Continuous glucose monitoring","Glucose","2026-05-15",{"date":120,"type":121},"2026-05-19","ACTUAL",{"date":123,"type":121},"2025-06-11",{"date":125,"type":106},"2040-12-31",{"name":5,"class":6},3]